The Global Bioinformatics Platforms Market Growth Is Accelerated By Genomic Data Analytics
Bioinformatics Platforms Market
Bioinformatics
platforms are extensively utilized for data management and analysis of genomic
and proteomic data. These platforms deliver advanced algorithms and statistical
tools to analyze vast amounts of biological data, which aids researchers in
deriving meaningful insights. The platforms integrate biological and clinical
data to accelerate genomic research and expedite drug discovery processes.
The
global Bioinformatics Platforms Market is estimated to be valued at US$ 13.15
Mn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period
2024 to 2031, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The increasing generation of extensive genomic data owing to reduced sequencing
costs is propelling the demand for effective data analytics tools.
Bioinformatics platforms deploy machine learning and artificial intelligence
techniques to gain deeper insights from genomic profiles. Their ability to
manage massive datasets and draw correlations provides strategic advantages to
academic and industrial researchers. As genomic research expands in scale and
scope, these platforms are able to efficiently handle big data analytics tasks.
Their roles in precision medicine have significantly grown as genomic and
clinical data integration is crucial for finding biomarkers and disease
targets. Advancements in analytics capabilities are expected to accelerate
genomic discoveries and support clinical applications over the forecast period.
Segment Analysis
The global bioinformatics platforms market is segmented into sequence analysis
platforms, sequence alignment platforms, sequence manipulation platforms and
other platforms. The sequence analysis platforms segment held the largest
market share in 2020, as these platforms aid in analyzing sequences of
nucleotides or amino acids, which is fundamental requirement for drug discovery
and various genomics applications. These platforms help in identifying
similarities and differences between biological sequences, which helps
researchers gain insight into molecular structure, genetic variations and
evolutionary relationships.
Key Takeaways
The Global
Bioinformatics Platforms Market Size is expected to witness high growth
over the forecast period of 2024 to 2031. The global Bioinformatics Platforms
Market is estimated to be valued at US$ 13.15 Mn in 2024 and is expected to
exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.
Regional
analysis: North America dominated the global market in 2020 and is expected to
maintain its dominance over the forecast period. This is attributed to presence
of major players and strong infrastructure for biotechnology and life science
research in the US and Canada. Moreover, rising investments by pharma and
biotech companies in R&D also support market growth.
Key players related content: Key players operating in the bioinformatics
platforms market are Canon Inc., Zebra Technologies Corporation,
Hewlett-Packard (HP) Inc., Epson America, Inc., BIXOLON. Major players are
focusing on new product launches and strategic partnerships to strengthen their
business portfolio and market share. For instance, in March 2021, Agilent
Technologies Inc. launched its new genetic analysis platform called Agilent
Cytogenomics Module 5.1, which supports high-resolution microarrays for
karyotyping and molecular analyses.
For more Insights, Read –
https://www.marketwebjournal.com/bioinformatics-platforms-market-market-size-and-share-analysis/
Comments
Post a Comment